The association between treatment integrity and treatment outcome of cognitive behavioural therapy for major depressive disorder.

Cogn Behav TherDec 16, 2025 (epub)
Clinical ResearchPsychiatry

N Zandstra, E Derksen, M F Miggiels et al.

✦ AI-curated · Sources linked

In 30 seconds

This study examined whether treatment integrity—therapist adherence to and competence in cognitive behavioural therapy (CBT)—was associated with outcomes for major depressive disorder (MDD). It was conducted within a pragmatic randomised non-inferiority trial comparing CBT with short-term psychodynamic supportive psychotherapy. Two sessions from each of 77 CBT cases were rated by independent assessors. Therapist competence, but not adherence, was significantly associated with treatment outcome; the association had a small effect size (ƒ² = 0.059). The findings suggest that how well therapists apply CBT techniques may matter more than strict protocol adherence.

Key findings

  • Therapist competence in CBT was significantly associated with treatment outcome, with a small effect size (ƒ² = 0.059).
  • Adherence to the CBT protocol was not significantly associated with treatment outcome.
  • The analysis included two randomly selected sessions from each of 77 CBT cases, rated by two independent assessors.

Why it matters

The findings highlight a distinction between delivering prescribed CBT components and applying them competently. For psychotherapy services, therapist skill may be a relevant factor when considering how to support treatment quality and outcomes. The observed association was small, however, and does not establish that increasing competence will cause better outcomes.

What to keep in mind

The analysis covered 77 CBT cases, with only two sessions rated per case; the reported association does not establish causality.

Source

Published in Cogn Behav Ther. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.